Mr. Malo, I would have to give you the same answer. None of our budget is tied to post-marketing surveillance. All I can say—and Ms. Ouellette has just supplied the figures to me— is that our participation in the National Prescription Drug Utilization Information System will cost $805,000 over the next year. As you know, the NPDUIS has many other participants, including the Canadian Institute for Health Information. We have no funding for post-marketing surveillance. We are not involved in this field at the moment.
On February 7th, 2008. See this statement in context.